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Abstract Cu2+ binding is so far the best characterized property
of the prion protein. This interaction has been mapped to the N-
terminal domain of the prion protein where multiple His resi-
dues occur largely embedded within the repetitive
PHGGGWGQ sequence known as octarepeats. When Cu2+ in-
teraction is studied using a solution of full-length bovine prion
protein containing six octarepeats at protein concentrations
above 25 WM, a drastic increase in solution turbidity is observed
due to the formation of insoluble cation^protein complexes that
appear as bidimensional polymer meshes. These bidimensional
meshes consist of a single layer of protein molecules crosslinked
by Cu2+ cations. Polymer formation is a cooperative process
that proceeds by nucleation of protein molecules with a Cu2+
site occupancy of above 2. These results support the hypothesis
that the N-terminal domain of prion protein is a ligand binding
module that promotes crosslinked assembly, and suggest the
existence of inter-repeat Cu2+ sites.
+ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
PrPC, the cellular prion protein, has become a key molecule
in brain for the understanding of the lethal neurodegenerative
disorders known as transmissible spongiform encephalopa-
thies [1,2]. In these diseases, PrPC is thought to undergo a
major conformational transition that promotes its perpetua-
tion in vivo as a complex, structurally de¢ned aggregate [2^4].
This transition is characterized by the stabilization of alter-
native conformers with a higher proportion of L-sheet struc-
ture relative to the normal physiological form. These confor-
mational changes, which occur in the C-terminal globular
domain, distort the solubility pattern, confer aggregation
properties and impair the normal clearance rate of the protein
[2,4^7].
PrPC is a Cu2þ binding protein and its function in cation
homeostasis is impaired on its conversion to PrPSc [8^25].
Cu2þ interaction has been mapped mainly at the N-terminal
region, which contains tandem repeats of the sequence
PHGGGWGQ known as octarepeats [11^17,20,25]. In the
absence of this cation this segment is randomly structured
and highly £exible but it becomes structurally constrained
upon metal chelation [15,20,25^27]. Each His residue of the
octarepeat segment has the capacity to harbor a Cu2þ atom in
a cooperative process characterized by a⁄nity constants that
lie in the femto- to micromolar range and Hill coe⁄cients of
2.6^4.2 [19,20,22,23,28]. In addition to the octarepeat region,
full-length PrP contains two other Cu2þ binding sites which
involve His residues located on either side of the amyloid
region [19,25,28].
Most studies on the interaction between PrPC-like folded
PrP (KPrP) and Cu2þ in solution have been performed using
low protein concentrations, and they were focused on intra-
molecular Cu2þ binding [22,25]. However, the multiplicity of
sites in the KPrP molecules and their location in £exible sol-
vent-exposed regions together with the propensity of Cu2þ to
form penta-coordinated complexes allows, in principle, the
formation of intermolecular complexes. Evidence for the par-
ticipation of KPrP in Cu2þ-mediated heteropolymer associa-
tions, such as with chromatographic matrices and glycosami-
noglycans [8,29^31], are available but the capacity of Cu2þ to
promote KPrP self-association has never been inspected. Us-
ing turbidity and solubility measurements, we have found that
Cu2þ binding triggers the formation of polymers of cation-
bound full-length bovine PrP containing six octarepeats
(KBoPrP(24^242)) in a process that depends on both the pro-
tein concentration and the Cu2þ site occupancy. The forma-
tion of insoluble Cu2þ^KBoPrP(24^242) complexes requires
binding of more than 2 Cu2þ equivalents. This allows the
crosslinking of di¡erent protein molecules into amorphous
bidimensional meshes stabilized by side contacts and sensitive
to proteolytic degradation. The results that we have obtained
support the role of the N-terminal domain of KPrP as a poly-
merization domain whose activity requires ligand binding, and
points to the existence of alternative and as yet undescribed
Cu2þ site geometries employed in this activity.
2. Materials and methods
2.1. KBoPrP(24^242) production
BoPrP(24^242) was expressed from pET11a plasmids in Escherichia
coli (BL21-DE3) and refolded after disul¢de bond formation as pre-
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viously described [30]. Before use, KBoPrP(24^242) was extensively
dialyzed against 20 mM MES pH 6.5, 50 mM NaCl and 0.03%
NaN3 to ensure the removal of citrate and cleared by centrifugation
at 10 000Ug for 30 min at 4‡C. When required, protein solutions were
concentrated by ultra¢ltration using YM-10 membranes (Amicon,
Millipore) and stored at 320‡C. The protein concentration was de-
termined spectrophotometrically in 6 M GdnCl (Pierce) using a molar
extinction coe⁄cient O280 of 62 280 M31 cm31.
2.2. Cation solutions
Cu2þ, Zn2þ and Mn2þ solutions were freshly prepared by dissolving
the required amount of the corresponding sulfate salts (Merck) in
boiled MilliQ water and then diluted into freshly N2-bubbled solu-
tions. Dilution of cation stock solutions into either bu¡er or protein
solutions occurred with no observable pH change. Cu2þ concentra-
tions were determined spectrophotometrically [32] using a calibration
curve veri¢ed by inductively coupled plasma optical emission spec-
trometry.
2.3. Turbidity measurements
The changes in protein solution turbidity were followed by measur-
ing the increase in the absorbance at 360 nm in an Ultrospec 3000pro
spectrophotometer (Amersham Pharmacia Biotech) using a thermo-
statted eight cell unit holder. Measurements were performed at 25‡C
using 0.1, 0.5 and 1 cm pathlength cuvettes. Samples were allowed to
equilibrate for 10 min before Cu2þ addition. Absorbance (A) readings
were corrected for bu¡er contribution and then converted to optical
density (OD) for normalization of data to 1 cm pathlength.
2.4. Solubility determination
KBoPrP(24^242) solutions in 20 mM MES pH 6.5 containing 50
mM NaCl and 0.03% NaN3 at varying concentrations were incubated
in the absence or presence of 1, 2, 3, 5, and 10 Cu2þ equivalents for 10
min at 25‡C. After removing aliquots for the determination of total
cation and protein content (T), the reaction mixtures were centrifuged
at 10 000Ug for 30 min at 4‡C, and separated into pellet (P) and
supernatant (S) fractions. The protein concentrations in the soluble
and pellet fractions were determined either spectrophotometrically in
6 M GdnCl (Pierce) using a molar extinction coe⁄cient O280 of 62 280
M31 cm31 or by quantitative dot-blot analysis. For dot-blot analysis,
samples were spotted in triplicate onto nitrocellulose membrane
mounted on a dot-blot cassette (Bio-Rad) and then denatured with
6 M GdnCl. After extensive washes, the membrane was blocked with
3% non-fat dry milk in TBST (10 mM Tris^HCl pH 7.4, 150 mM
NaCl, 0.05% Tween 20) and then incubated with monoclonal anti-
body 6H4. Detection was performed using a horseradish peroxidase-
conjugated secondary antibody (Sigma) and ChemiLucent reagent
(Chemicon). Signal detection and analysis were carried out with the
ChemiDoc Bio-Rad system and the Quantity One software. For pellet
concentration, protein and cation contents were referenced to the total
volume.
2.5. Atomic force microscopy (AFM)
Pellets from KBoPrP(24^242) solutions treated with 3 Cu2þ equiv-
alents were dispersed in 20 mM MES pH 6.5 containing 50 mM NaCl
and 0.03% NaN3 at 1 mg/ml protein concentration. Typically, 50 Wl of
the freshly prepared resuspension was deposited onto a mica surface
that had just been freshly cleaved and immersed in 2 M KCl, allowed
to adsorb for 1 h and then extensively washed with bu¡er. Images
were taken with an atomic force microscope (Nanotec Electro¤nica,
Madrid, Spain) operated in contact or jump mode, with silicon nitride
tips with a force constant of 0.12 N/m (DI Instruments). The samples
were maintained in bu¡er solution during imaging.
3. Results
3.1. Cu2+ induces the aggregation of KBoPrP(24^242)
Addition of increasing molar equivalents of Cu2þ ions to
solutions of KBoPrP(24^242) induces the appearance of tur-
bidity that can be monitored by measuring the absorbance
at 360 nm. This turbidity clari¢es upon centrifugation at
10 000Ug for 30 min, yielding transparent supernatants with
decreased protein concentration indicating the formation of
KBoPrP(24^242) insoluble aggregates. Kinetic traces from 68
WM KBoPrP(24^242) solutions at increasing Cu2þ equivalen-
ces are shown in Fig. 1. The increases in A360 are speci¢cally
related to Cu2þ interaction since its replacement by Zn2þ or
Mn2þ does not modify the initial A360 reading. Addition of
Cu2þ in the absence of protein does not change the initial
reading and when Cu2þ is added as a 1:2 complex with a
chelator (nitrilotetraacetate and citrate), the increase in
vA360 shifts to a higher total concentration of Cu2þ concom-
itant with the pH-corrected complex stability constant (Fig.
Fig. 1. Cu2þ-induced aggregation of KBoPrP followed by turbidity measurements. A: KBoPrP(24^242) solutions (68 WM) in 20 mM MES pH
6.5 containing 50 mM NaCl and 0.03% NaN3 were placed in cuvettes of 0.1 or 0.5 cm pathlength and equilibrated for 5 min previous to the
addition of 0, 1, 2, 3, 4 or 5 Cu2þ equivalents and their absorbance at 360 nm measured as a function of time in 0.1 cm pathlength cells with-
out stirring. Displayed traces were corrected by the contribution of the corresponding protein-free baselines. B: E¡ect of Cu2þ availability on
the turbidity increase. KBoPrP(24^242) solutions (68 WM) in 20 mM MES pH 6.5 containing 50 mM NaCl and 0.03% NaN3 were titrated step-
wise with Cu2þ in the absence (a) or presence of two-fold molar excess of citrate (F) or nitrilotetraacetate (E) carriers. Before taking the A360
readings in 0.1 cm cuvettes, samples were allowed to equilibrate for 15 min and then vortexed by double inversion.
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1B) [33]. The appearance of turbidity is not prevented by the
presence of non-ionic detergents such as Tween 20 and Brij
96-V below and above the micellar concentration (data not
shown). These observations exclude the participation of either
side reactions arising from the intrinsic instability of Cu2þ
solutions at the working pH, or any Cu2þ-induced increase
on the hydrophobicity of the protein surface in contributing
to the observed turbidity in the Cu2þ-induced protein aggre-
gation event.
The time dependence of the increase in the A360 readings
showed that the changes occurred rapidly and the maximum
was attained in less than 5 min (Fig. 1A). This pattern was
conserved for di¡erent protein batches excluding artifacts
stemming from conformational heterogeneities and the pres-
ence of undesired protein covalent modi¢cations [34]. For a
¢xed protein concentration (68 WM) increasing the Cu2þ
equivalents had no signi¢cant e¡ect on the initial slope but
altered the maximum A360 (Fig. 1A). Importantly, the max-
imum A360 remained constant over a period of time long
enough to exclude fast reorganization events that would clear
the optical path. Comparison of steady-state values from end-
point and stepwise Cu2þ titrations (Fig. 1A,B) showed di¡er-
ences in the vA360 and in the dependence on increasing Cu2þ
saturation that suggest distinct ¢nal states di¡ering in either
concentration, size or both. In addition, once reached the
maximum value of A360 dilution of the samples from 68 WM
to 42.5 WM protein concentration caused a reduction in the
A360 that was proportional to the dilution factor (data not
shown), indicating the lack of reversibility over the time scale
employed. This observation indicated that the Cu2þ-induced
aggregation is kinetically favored and its evolution, if any, to
a thermodynamically more favored state occurs would be a
very slow process.
3.2. KBoPrP(24^242) in complex with Cu2+ is the aggregating
species
To get insight into the nature of the aggregating species we
performed a quantitative analysis of the composition of the
pellet fractions obtained from a 30 min centrifugation at
10 000Ug of KBoPrP(24^242) solutions after the addition of
increasing equivalents of Cu2þ (Fig. 2A). For 42.5 WM
KBoPrP(24^242) the insoluble fraction contains both protein
and Cu2þ and becomes enriched in both components as the
number of added Cu2þ equivalents increases. It must be
stressed that in the absence of the protein, 87% of the Cu2þ
remains in solution up to the concentration corresponding to
10 equivalents excluding artifacts arising from possible Cu2þ
instability except for the samples prepared at 10-fold molar
excess of the cation. Therefore, this result shows that the
aggregating species is the Cu2þ-bound protein.
Analysis of the Cu2þ saturation function of the insoluble
fraction of KBoPrP(24^242) solutions at 42.5 and 85.2 WM
initial concentrations reveals an increase in Cu2þ site occu-
pancy as the total Cu2þ equivalents added increases (Fig.
2B), from 2.9 up to a value between 4 and 5. The lower limit
of the saturation function indicates that saturation of at least
half of the sites is critical for the formation of the insoluble
aggregates. On the other hand, the upper limit of the satura-
tion agrees with the 80% reduction in the theoretical maxi-
mum value of 6 due to pH e¡ects [22,30]. Furthermore, for a
total Cu2þ equivalence of 3, the saturation function of the
insoluble phase becomes 2.9U 0.2 at protein concentrations
Fig. 2. Insoluble polymers are formed by KBoPrP(24^242) in com-
plex with Cu2þ. A: Cu2þ (a) and KBoPrP(24^242) (b) concentra-
tions in the pellet fractions of a 10 000Ug centrifugation for 30 min
at 4‡C of 42.5 WM protein solutions with increasing the addition of
Cu2þ equivalents. Concentrations are referenced to the total initial
volume. B: Dependence of Cu2þ^KBoPrP(24^242) composition on
the number of added Cu2þ equivalents to 42.5 (b) and 85.2 (a) WM
protein solutions. C: Variation of Cu2þ site occupancy in the in-
soluble KBoPrP(24^242) polymers with the initial concentration of
protein:Cu2þ 1:3 mixtures. Displayed data are the average of three
independent measurements, each with duplicate samples.
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above 40 WM (Fig. 2C), indicating that the threshold occu-
pancy of sites for the formation of insoluble aggregates is
independent of the protein concentration.
3.3. The insoluble Cu2+^KBoPrP(24^242) complexes are
bidimensional meshes with lateral contacts among protein
monomers
Formation of insoluble aggregates can be due to either
intramolecular or intermolecular Cu2þ binding. If the loss of
solubility upon Cu2þ binding was caused by a cation cross-
linking event, then for a ¢xed Cu2þ concentration increasing
KBoPrP(24^242) concentration would decrease the aggrega-
tion process since the excess of protein would reduce the
probability of intermolecular bridging. For a constant concen-
tration of Cu2þ of 129 WM, increasing KBoPrP(24^242) con-
centration from 43 to 86 WM reduces the percentage of protein
precipitation from 39 (16.77 WM) to 10% (8.6 WM). Therefore,
the aggregation process could be attributed to the formation
of intermolecular Cu2þ crosslinks. To verify the existence of
Cu2þ-induced contact sites we monitored the formation of the
complexes by AFM. Protein^Cu2þ complexes prepared with
3 cation equivalents were isolated by centrifugation and trans-
ferred to 2 M KCl-treated freshly cleaved mica by dispersion
in cation-depleted bu¡er. After 1 h of incubation and exten-
sive washing, the inspection of the surface revealed an amor-
phous mesh of protein with a thickness of about 3 nm that
corresponds to that expected for a single layer of a globular
protein of about 23.5 kDa as in the case with KBoPrP(24^242)
(Fig. 3). The extremely invariant thickness compared to the
non-periodic bidimensional structure featured by holes and
surface irregularities denoted a preferential orientation of
the contacts among protein molecules in the plane parallel
to the mica surface. Analysis of multiple samples and regions
indicated large polydispersity in the direction parallel to the
mica surface, with polymers displaying full widths at half
height varying from 20 to 50 nm. These images agreed with
that expected for a polymeric protein mesh organized prefer-
entially in a layer sustained by Cu2þ staples among molecules.
3.4. Cu2+-induced KBoPrP(24^242) aggregation is cooperative
and follows a nucleated polymerization mechanism
Polymerization reactions that proceed by a condensation
mechanism typically exhibit a cooperative dependence on
the protomer condensation and a threshold or critical concen-
tration for assembly. To determine whether Cu2þ-mediated
KBoPrP(24^242) aggregation displays this characteristic,
the relation of the maximum vOD360 as a function of
KBoPrP(24^242) concentration in the presence of 3 Cu2þ
equivalents was examined (Fig. 4A). The results show that
the reaction is biphasic. The ¢rst phase is observed at
KBoPrP(24^242) below 40 WM and consists of a slight increase
in vOD360. The second phase spans KBoPrP(24^242) concen-
trations in the 40^85 WM range and consists of a very steep
rise on vOD360 with increasing protein concentration. Since
for KBoPrP(23^232) concentrations above 40 WM the addition
of 3 Cu2þ equivalents results in insoluble polymers containing
3 Cu2þ per protein mol (Fig. 4A), the solubility data can be
used to explore the polymerization mechanism. Fig. 4B shows
the analysis of the partition of KBoPrP(24^242) in the pres-
ence of 3 Cu2þ equivalents between the soluble and the in-
soluble phases as a function of KBoPrP(24^242) concentra-
tion. This partition pattern agrees with a nucleated
polymerization with a critical concentration of 21U 4 WM in
which the species undergoing the polymerization is the pro-
tein^Cu2þ complex. The existence of such an equilibrium pro-
cess is further supported by the complete degradation of the
Cu2þ^KBoPrP(24^242) polymers prepared at a 3:1 molar ra-
tio, both in the absence and in the presence of 2% sodium
sarcosinate, by proteinase K (Fig. 4C).
4. Discussion
The N-terminal domain of PrP has been recognized as a
regulatory module in the overall metabolic process leading to
the molecule’s structural conversion, aggregation and deposi-
tion [35^38]. Among its functions, Cu2þ binding is the best
known at the molecular level and has been described as the
sequential acquisition of an individual Cu2þ cation by each of
the PHGGGWGQ octarepeat motifs within the protein mol-
ecule with the subsequent folding of the polypeptide chain
around the cation [13,15,17,20,25]. Additionally, Cu2þ bind-
ing also drives the participation of PrP through its N-terminal
domain in hetero-association reactions [8,29^31], that support
alternative geometries in Cu2þ sites. An immediate conse-
quence of increasing the protein concentration regime used
for Cu2þ binding studies is the occurrence of a protein poly-
merization event which agrees with previous studies with PrPC
Fig. 3. AFM analysis of the morphology of Cu2þ-bound
KBoPrP(24^242) insoluble complexes. A: AFM images of
KBoPrP(24^242) polymers induced by Cu2þ binding. The white bar
represents 200 nm and the height (black to white color scale) is
4 nm. B: Distance pro¢le of a selected region (white bar) of the im-
age shown in the top panel. The vertical axis corresponds to the
thickness of the structures while the horizontal axis indicates the
distance (related to the polymer width) of the selected segment.
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extracted from transgenic mouse brains and from transfected
cells [39]. However, contrary to PrPC in crude detergent ex-
tracts, the observed in vitro polymerization is speci¢c for
Cu2þ and does not produce fully proteinase K-protected
forms probably due to the absence of other membrane-resi-
dent molecule [30,31].
The polymerization process, followed by both turbidity and
solubility measurements, requires protein concentrations
above 21U 4 WM and the saturation of more than 2 sites
with Cu2þ. Importantly, we ¢nd that the formation of insolu-
ble complexes takes place both when Cu2þ is presented as a
free cation and as a chelate complex. This also rules out
artifacts arising from Cu2þ instability in aqueous media. In-
soluble Cu2þ-KBoPrP(24^242) polymers appear as bidimen-
sional meshes consisting of a single layer of protein molecules
stabilized by multiple side to side contacts in our AFM anal-
ysis. On structural grounds, these side to side contacts and the
reduction of the degree of polymerization with increasing pro-
tein concentration for a ¢xed Cu2þ concentration support the
proposal that the aggregating entity arises from Cu2þ cross-
linking di¡erent KBoPrP(24^242) molecules. In other words,
Cu2þ can bind to KPrP both intramolecularly and intermolec-
ularly, the mode of binding being determined by the range of
the protein concentrations employed.
The crystal structure of the Cu2þ complex of the minimal
binding site in the PrP molecule (HGGGW) showed Cu2þ in a
¢ve-fold coordination geometry with the near-equatorial co-
ordinate bonds to the nitrogen of the His imidazole side chain
and of the two sequential Gly residues and the amide carbonyl
oxygen of the second Gly, and as the axial ligand and an
oxygen from a water molecule that is bridged by hydrogen
bonding the indole nitrogen of the Trp [20]. This structure, in
which the intramolecular Cu2þ binding is a short-range, intra-
repeat process, has been shown to be compatible with com-
pletely Cu2þ-saturated, full-length KPrP at low protein con-
centrations [25]. To allow intermolecular sites we must
postulate the existence of an as yet undescribed alternative
geometry in which Cu2þ ‘staples’ together di¡erent repeats.
This interrepeat geometry may either preserve the nature of
the coordinating groups, which may belong to di¡erent poly-
peptide chains, or consist of a fully divergent geometry. Tak-
ing into account steric impediments and the knowledge ob-
tained from other ligand-induced polymerizing systems such
as, for example, that of glutamine synthetase mediated by
Zn2þ or Cu2þ, a di¡erent geometry for the interrepeat site
seems more plausible. For instance, self-assembly into tubular
polymers of the dodecameric glutamine synthetase has been
shown to occur by virtue of cation coordination to two sites
involving a pair of His residues each belonging to a di¡erent
polypeptide chains with no structure cost [40].
The ¢nding of Cu2þ binding-linked KBoPrP(24^242) poly-
merization necessitates the recognition of the N-terminal do-
main of KPrP to be an alternative self-associating domain.
However, in contrast to the aggregation mediated by the
C-terminal domain, the N-terminal domain polymerizations
are linked by ligand binding events and, in the case of that
involving Cu2þ, do not impair the proteolytic clearance of the
prion protein. In fact, we can hypothesize that the regulatory
role that the N-terminal domain has in the conversion of PrPC
to PrPSc is the consequence of its capacity to participate in
ligand-linked associations. Spatial coincidence of Cu2þ^KPrP
bound species at the cell compartments at which exogenous
prion recognition and conformationally directed transition oc-
cur, opens up the possibility that Cu2þ-bound KPrP species
are both the receptors as well as the substrates for the con-
version of PrPC to PrPSc.
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